Dynamic Technology Lab Private Ltd reduced its holdings in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 80.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,035 shares of the technology company’s stock after selling 25,544 shares during the period. Dynamic Technology Lab Private Ltd’s holdings in Veeva Systems were worth $1,267,000 at the end of the most recent quarter.
A number of other hedge funds also recently added to or reduced their stakes in the business. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in shares of Veeva Systems during the third quarter worth $26,000. Advisors Asset Management Inc. purchased a new stake in Veeva Systems during the 1st quarter worth about $28,000. Blue Trust Inc. raised its position in Veeva Systems by 3,460.0% in the 2nd quarter. Blue Trust Inc. now owns 178 shares of the technology company’s stock valued at $33,000 after purchasing an additional 173 shares in the last quarter. DT Investment Partners LLC purchased a new position in shares of Veeva Systems in the 2nd quarter valued at about $35,000. Finally, Mather Group LLC. grew its position in shares of Veeva Systems by 166.3% during the second quarter. Mather Group LLC. now owns 253 shares of the technology company’s stock worth $46,000 after buying an additional 158 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors and hedge funds.
Veeva Systems Stock Down 0.0 %
VEEV opened at $226.88 on Wednesday. The business has a 50 day moving average price of $214.98 and a two-hundred day moving average price of $201.48. Veeva Systems Inc. has a 52 week low of $165.12 and a 52 week high of $240.68. The company has a market cap of $36.74 billion, a PE ratio of 60.50, a P/E/G ratio of 2.09 and a beta of 0.81.
Insiders Place Their Bets
In other Veeva Systems news, insider Thomas D. Schwenger sold 1,126 shares of Veeva Systems stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $240.01, for a total value of $270,251.26. Following the sale, the insider now owns 27,013 shares of the company’s stock, valued at approximately $6,483,390.13. The trade was a 4.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 10.50% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on VEEV. Truist Financial raised their target price on shares of Veeva Systems from $197.00 to $207.00 and gave the company a “hold” rating in a report on Tuesday, September 3rd. Guggenheim lifted their price objective on shares of Veeva Systems from $233.00 to $249.00 and gave the stock a “buy” rating in a research report on Tuesday, October 1st. StockNews.com raised Veeva Systems from a “hold” rating to a “buy” rating in a report on Saturday, November 9th. Scotiabank started coverage on Veeva Systems in a research report on Monday, November 18th. They set a “sector perform” rating and a $235.00 price objective for the company. Finally, Citigroup raised their target price on Veeva Systems from $256.00 to $273.00 and gave the stock a “buy” rating in a research report on Tuesday, August 27th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, Veeva Systems has an average rating of “Moderate Buy” and a consensus price target of $236.92.
Read Our Latest Report on Veeva Systems
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Articles
- Five stocks we like better than Veeva Systems
- The How and Why of Investing in Gold Stocks
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- What is MarketRank™? How to Use it
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Find and Profitably Trade Stocks at 52-Week Lows
- Why Amazon Shares May Never Trade Below $200 Again
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.